Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Genomic assessments of the frequent loss of heterozygosity region on 8p21.3-p22 in head and neck squamous cell carcinoma.

Ye H, Pungpravat N, Huang BL, Muzio LL, Mariggi├▓ MA, Chen Z, Wong DT, Zhou X.

Cancer Genet Cytogenet. 2007 Jul 15;176(2):100-6.

2.

Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis.

Lee DJ, Sch├Ânleben F, Banuchi VE, Qiu W, Close LG, Assaad AM, Su GH.

Cancer Biol Ther. 2010 Oct 1;10(7):689-93. doi: 10.4161/cbt.10.7.12886. Epub 2010 Oct 1.

3.

Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.

Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, Weichselbaum R, Kuo MJ, Maher ER, Latif F.

Eur J Cancer. 2002 Aug;38(12):1585-92.

PMID:
12142046
4.

Identification of a candidate tumor suppressor gene RHOBTB1 located at a novel allelic loss region 10q21 in head and neck cancer.

Beder LB, Gunduz M, Ouchida M, Gunduz E, Sakai A, Fukushima K, Nagatsuka H, Ito S, Honjo N, Nishizaki K, Shimizu K.

J Cancer Res Clin Oncol. 2006 Jan;132(1):19-27. Epub 2005 Sep 17.

PMID:
16170569
5.

Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.

Marescalco MS, Capizzi C, Condorelli DF, Barresi V.

J Oral Pathol Med. 2014 Jan;43(1):20-7. doi: 10.1111/jop.12087. Epub 2013 Jun 10.

PMID:
23750501
7.

Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.

el-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V.

Cancer Res. 1995 Jun 15;55(12):2656-9.

8.

Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.

Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC, Nisen PD.

J Natl Cancer Inst. 1994 Oct 19;86(20):1524-9.

PMID:
7932807
9.
10.

Association of deletion in the chromosomal 8p21.3-23 region with the development of invasive head & neck squamous cell carcinoma in Indian patients.

Bhattacharya N, Tripathi A, Dasgupta S, Sabbir MG, Roy A, Sengupta A, Roy B, Roychowdhury S, Panda CK.

Indian J Med Res. 2003 Aug;118:77-85.

PMID:
14680203
11.

Definition of a region of loss of heterozygosity at chromosome 11q23.3-25 in head and neck squamous cell carcinoma using laser capture microdissection technique.

Tan D, Wiseman S, Zhou Y, Li Q, Ward P, Slocum HK, Alrawi S, Loree T, Hicks W, Rigual N, Anderson G, Stoler D.

Diagn Mol Pathol. 2004 Mar;13(1):33-40.

PMID:
15163007
12.

Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.

Borkosky SS, Gunduz M, Nagatsuka H, Beder LB, Gunduz E, Ali MA, Rodriguez AP, Cilek MZ, Tominaga S, Yamanaka N, Shimizu K, Nagai N.

J Cancer Res Clin Oncol. 2009 May;135(5):703-13. doi: 10.1007/s00432-008-0507-y. Epub 2008 Nov 8.

PMID:
18998165
13.

Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.

Gunduz M, Ouchida M, Fukushima K, Ito S, Jitsumori Y, Nakashima T, Nagai N, Nishizaki K, Shimizu K.

Oncogene. 2002 Jun 27;21(28):4462-70.

14.

Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.

Gunduz M, Nagatsuka H, Demircan K, Gunduz E, Cengiz B, Ouchida M, Tsujigiwa H, Yamachika E, Fukushima K, Beder L, Hirohata S, Ninomiya Y, Nishizaki K, Shimizu K, Nagai N.

Gene. 2005 Aug 15;356:109-17.

PMID:
15935570
15.

Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma.

Coon SW, Savera AT, Zarbo RJ, Benninger MS, Chase GA, Rybicki BA, Van Dyke DL.

Int J Cancer. 2004 Aug 20;111(2):206-12.

16.

Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.

Papadimitrakopoulou VA, Oh Y, El-Naggar A, Izzo J, Clayman G, Mao L.

Clin Cancer Res. 1998 Mar;4(3):539-44.

17.

Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas.

Beder LB, Gunduz M, Ouchida M, Fukushima K, Gunduz E, Ito S, Sakai A, Nagai N, Nishizaki K, Shimizu K.

Lab Invest. 2003 Jan;83(1):99-105.

PMID:
12533690
18.

DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma.

Hewitt C, Wilson P, McGlinn E, MacFarlane G, Papageorgiou A, Woodwards RT, Sloan P, Gollin SM, Paterson I, Parkinson KK, Read AP, Thakker N.

Cancer Lett. 2004 Jun 25;209(2):207-13.

PMID:
15159023
19.

Unchanged frequency of loss of heterozygosity and size of the deleted region at 8p21-23 during metastasis of lung cancer.

Kurimoto F, Gemma A, Hosoya Y, Seike M, Takenaka K, Uematsu K, Yoshimura A, Shibuya M, Kudoh S.

Int J Mol Med. 2001 Jul;8(1):89-93.

PMID:
11408955
20.

Deletion mapping of chromosome 4 in head and neck squamous cell carcinoma.

Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WK, Steck PA.

Oncogene. 1997 Jan 23;14(3):369-73.

Items per page

Supplemental Content

Write to the Help Desk